Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret G House

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 18, 2014
Prostate cancer prevention: agent development strategiesHoward L Parnes, Margaret G House, Joseph A Tangrea
Current Opinion in Oncology|March 23, 2013
Prostate cancer prevention: strategies for agent developmentHoward L Parnes, Margaret G House, Joseph A Tangrea
The Journal of Urology|January 10, 2004
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolioHoward L Parnes, Margaret G House, Jacob Kagan, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 3: Prevention of bladder cancerSeth P Lerner, H Barton Grossman, Edward M Messing, et al.
The Prostate|October 23, 2020
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillanceDavid Jarrard, Mikolaj Filon, Wei Huang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 23, 2017
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R Gee, Daniel R Saltzstein, KyungMann Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.
BMC Cancer|January 28, 2025
ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIVDelia Pinto-Santini, Emilia M Jalil, Giovana Teixeira Fernandes, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 18, 2014
Prostate cancer prevention: agent development strategiesHoward L Parnes, Margaret G House, Joseph A Tangrea
Current Opinion in Oncology|March 23, 2013
Prostate cancer prevention: strategies for agent developmentHoward L Parnes, Margaret G House, Joseph A Tangrea
The Journal of Urology|January 10, 2004
Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolioHoward L Parnes, Margaret G House, Jacob Kagan, et al.
American Journal of Clinical and Experimental Urology|October 22, 2016
Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D<sub>3</sub>) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomyDavid Jarrard, Badrinath Konety, Wei Huang, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 20, 2014
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancerJill M Kolesar, Marcia Pomplun, Tom Havighurst, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 3: Prevention of bladder cancerSeth P Lerner, H Barton Grossman, Edward M Messing, et al.
The Prostate|October 23, 2020
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillanceDavid Jarrard, Mikolaj Filon, Wei Huang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 23, 2017
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue BiomarkersJason R Gee, Daniel R Saltzstein, KyungMann Kim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 6, 2019
A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy VolunteersJill M Kolesar, Shannon Andrews, Heather Green, et al.
BMC Cancer|January 28, 2025
ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIVDelia Pinto-Santini, Emilia M Jalil, Giovana Teixeira Fernandes, et al.
Pageof 2